New Diabetes Drug, Admelog (Insulin Lispro), Gets FDA OK Under ' Abbreviated ' Pathway
MONDAY, Dec. 11, 2017 -- Admelog (insulin lispro), a short-acting form of insulin, has been approved by the U.S. Food and Drug Administration to treat people with either type of diabetes, for patients aged three years and older.
It ' s the first drug...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Diabetes | Endocrinology | Food and Drug Administration (FDA) | General Medicine | Humalog | Insulin